Researchers developed MAGIC, an AI-based system integrating automated microscopy and genomics to study chromosomal abnormalities linked to cancer.
Key Details
- 1MAGIC uses automated microscopy, AI-driven image analysis, and single-cell genome sequencing to identify and tag abnormal cells.
- 2The system can analyse nearly 100,000 cells in less than a day, vastly exceeding manual methods.
- 3Chromosomal abnormalities were seen in just over 10% of cell divisions, doubling with mutated p53 gene.
- 4MAGIC relies on a laser and photoconvertible dye to mark target cells, facilitating further analysis.
- 5The tool is versatile and can be trained to identify a variety of visually distinct cellular features.
Why It Matters
MAGIC represents a significant step forward in combining imaging AI and genomic methods for the high-throughput study of cellular abnormalities, offering potential advances in cancer detection and understanding cancer origins. Such AI-driven image analysis tools could pave the way for faster, more precise research and diagnostics in radiology and oncology.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.